The Pablove Foundation Pediatric Leukemia Research Seed Grant 2026 supports pilot research into childhood mixed-lineage leukemia, mixed-phenotype acute leukemia and KMT2A-rearranged leukemias.
Priorities include treatment resistance, lineage switching and targeted therapies with lower toxicity. The award helps investigators generate preliminary evidence for larger funding applications.
Eligibility Criteria
- Hold an MD, PhD or equivalent degree.
- Be affiliated with an accredited academic medical centre or paediatric research institution.
- Focus on paediatric MLL, MPAL or KMT2A-rearranged leukemias.
- Propose an innovative, standalone research project.
- Postdoctoral fellows and junior faculty are encouraged to apply; established laboratories are also eligible.
- The institution must accept a 0% indirect-cost rate.
Funding Details
- Award: US $50,000.
- Duration: 12 months.
- Supports direct research expenses, including reagents, sequencing and research staff salaries.
Deadline
- December 1, 2026.
Further Information
- Official call and requirements
- Apply through ProposalCentral